2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
4.950
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EDT - Market closed
2seventy bio Employees
2seventy bio had 274 employees as of December 31, 2023. The number of employees decreased by 151 or -35.53% compared to the previous year.
Employees
274
Change (1Y)
-151
Growth (1Y)
-35.53%
Revenue / Employee
$138,182
Profits / Employee
-$208,931
Market Cap
259.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 274 | -151 | -35.53% |
| Dec 31, 2022 | 425 | -12 | -2.75% |
| Dec 31, 2021 | 437 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TSVT News
- 3 days ago - 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 14 days ago - 2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT - Business Wire
- 17 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc. - PRNewsWire
- 17 days ago - Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal - Benzinga
- 17 days ago - Top 3 Health Care Stocks That May Keep You Up At Night In Q1 - Benzinga
- 17 days ago - Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million - Reuters
- 18 days ago - 2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - Business Wire
- 4 weeks ago - 2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference - Business Wire